-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The gut microbiome is expected to be used to treat type 2 diabetes (T2D), and measures to change the gut microbiota, such as oral probiotics or berberine (BBR), are beneficial to the balance of metabolism
diabetes
The study included 49 newly diagnosed T2D patients from 20 centers in China and randomly assigned (1:1:1:1).
diagnosis
The results showed that as the main results, probiotics + BBR (mean of least squares [95% CI], -1.
In summary, the results of this study reveal that the anti-diabetic effect of BBR on T2D is related to human microorganisms
Original source:
Yifei Zhang, et al.
Gut microbiome-related effects of berberine and probiotics on type 2 diabetes (the PREMOTE study)
in this message